Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • karve
    Member
    • Feb 2011
    • 12

    #1

    Hello From Shantanu Karve - IT for years and years

    Visiting friends and seeing their autistic son jolted me and made me think more about medical issues than I have before. I'm a IT person.

    Separately,I take an interest in financial stuff and one of the fund managers I respect ( one of perhaps 10 ! ) - John Hussman, funds autistic research, also takes part in ( as the team statistician ) and wrote up a paper on a GWAS study of autism. He posted it on his funds website recently and I actually read it all the way through and found it interesting.

    Which is a long way round to saying that's why I've got interested in NGS. I'll always be coming at it from the cloud computing perspective - I've already got as far as setting up a MapReduce, Hadoop, Mahout ( framework for machine intelligence ) cluster.

    Now I've just go to figure out which of the various areas of NGS I want to go for!

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
30 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
39 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
45 views
0 reactions
Last Post SEQadmin2  
Working...